Cost effectiveness of posaconazole versus standard azole therapy for the prevention of invasive fungal infections in high-risk patients in Switzerland

被引：0
|
作者：
Greiner, R. [1 ]
Meier, Y. [2 ]
O'Sullivan, A. [3 ]
Imhof, A. [4 ]
机构：
[1] Consultant Hlth Econ, Lorrach, Germany
[2] Essex Chemie AG, Luzern, Switzerland
[3] i3 Innovus, Medford, MA USA
[4] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Posaconazole Compared with Standard Azole Therapy for Prevention of Invasive Fungal Infections in Patients at High Risk in Switzerland
    Greiner, Roger-Axel
    Meier, Yvonne
    Papadopoulos, George
    O'Sullivan, Amy K.
    Imhof, Alexander
    [J]. ONCOLOGY, 2010, 78 (3-4) : 172 - 180
  • [2] Cost-effectiveness of posaconazole versus standard azole therapy in the prevention of invasive fungal infections among high-risk neutropenic patients in the US
    O'Sullivan, Amy K.
    Pandya, Ankur
    Thompson, David
    Papadopoulos, George
    Weinstein, Milton C.
    Perfect, John R.
    Langston, Amelia
    [J]. BLOOD, 2006, 108 (11) : 945A - 945A
  • [3] COST-EFFECTIVENESS OF ANTIGUNGAL PROPHYLAXIS WITH POSACONAZOLE VERSUS STANDARD AZOLE THERAPY IN THE PREVENTION OF INVASIVE FUNGAL INFECTIONS AMONG HIGH RISK HAEMATOLOGY PATIENTS IN CZECH REPUBLIC
    Suchankova, E.
    Dolezal, T.
    Simonova, J.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A380 - A380
  • [4] COST-EFFECTIVENESS OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE IN THE PREVENTION OF INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN SINGAPORE
    Fust, K.
    Weinstein, M. C.
    Gomez-Rey, G.
    Xie, Y.
    Hsu, T. Y.
    Pawar, V
    Hsu, L. Y.
    Tan, B. H.
    O'Sullivan, A. K.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A138 - A139
  • [5] Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
    Grau, Santiago
    de la Camara, Rafael
    Sabater, Francisco J.
    Jarque, Isidro
    Carreras, Enric
    Casado, Miguel A.
    Sanz, Miguel A.
    [J]. BMC INFECTIOUS DISEASES, 2012, 12
  • [6] Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
    Santiago Grau
    Rafael de la Cámara
    Francisco J Sabater
    Isidro Jarque
    Enric Carreras
    Miguel A Casado
    Miguel A Sanz
    [J]. BMC Infectious Diseases, 12
  • [7] Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies
    Hachem, Ray
    Assaf, Andrew
    Numan, Yazan
    Shah, Pankil
    Jiang, Ying
    Chaftari, Anne-Marie
    Raad, Issam I.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (03) : 384 - 388
  • [8] COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO
    Rely, K.
    Pierre, K. A.
    Salinas, E. G.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A50 - A50
  • [9] Economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in Canada
    Monfared, Amir A. Tahami
    O'Sullivan, Amy K.
    Rotstein, Coleman
    Papadopoulos, George
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (02): : 59 - 64
  • [10] COST UTILITY OF POSACONAZOLE VERSUS FLUCONAZOLE/ITRACONAZOLE THERAPY IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS AMONG HIGH-RISK NEUTROPENIC PATIENTS IN MEXICO
    Rely, K.
    Pierre, K. A.
    Salinas, E. G.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A490 - A491
12345